Oct 1, 2021Julienne Hearn Joins Sexton Riley LLPSexton Riley LLP is proud to announce that Julienne Hearn has joined the firm as a partner, as of October 1, 2021. Julienne is a...
May 2, 2020Janssen - Fate Therapeutics iPSC CAR NK and CAR-T CollaborationSexton Riley LLP Represents Janssen in Worldwide Collaboration Agreement with Fate Therapeutics for Novel iPSC-derived Cell-based Cancer...
Dec 29, 2018Janssen - argenx Cusatuzumab CollaborationSexton Riley LLP Represents Janssen Affiliate Cilag GmbH International in Worldwide Collaboration and License Agreement with argenx for...
Dec 30, 2017Janssen - Legend Biotech CAR-T CollaborationSexton Riley LLP Represents Janssen in Worldwide Collaboration and License Agreement with Chinese Company Legend Biotech to Develop...
May 30, 2017Janssen-Protagonist IL-23R CollaborationSexton Riley LLP Represents Janssen in Worldwide Exclusive License and Collaboration Agreement with Protagonist Therapeutics May 2017...